Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas Enzler
Thomas Enzler
University of Michigan
Medicine
Chemotherapy
Internal medicine
Cancer
T cell
3
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I/II trial to evaluate cabozantinib in patients with advanced hepatocellular carcinoma with Child-Pugh class B cirrhosis after first-line therapy.
2021
Journal of Clinical Oncology
Thomas Enzler
Neehar D. Parikh
Chih-Yi Liao
Aparna Kalyan
David Hsieh
Kent A. Griffith
Vaibhav Sahai
Show All
Source
Cite
Save
Citations (0)
Emerging antibody therapies for pancreatic adenocarcinoma: a review of recent phase 2 trials.
2021
Expert Opinion on Emerging Drugs
Jasmeet Kaur
Paramveer Singh
Thomas Enzler
Vaibhav Sahai
Show All
Source
Cite
Save
Citations (2)
872 Neoadjuvant chemoradiotherapy enhances T cell infiltration in pancreatic ductal adenocarcinoma but high percentage of regulatory T cells associates with poor survival
2020
Journal for ImmunoTherapy of Cancer
Benjamin Fullerton
Robyn D. Gartrell
Thomas Enzler
Pan Kim
Ladan Fazlollahi
Andrew Chen
Subha Perni
Stuart P. Weisberg
Emanuelle M. Rizk
Eun Jeong Oh
Xinzheng Guo
Codruta Chiuzan
Raul Rabadan
Donna L. Farber
Helen Remotti
David P. Horowitz
Yvonne M. Saenger
Show All
Source
Cite
Save
Citations (0)
1